Amadeus Capital Partners has hit a £110m final close for its latest early stage, deeptech investment fund.Amadeus V Technology Fund was boosted by...

Mike Murphy Contributor Mike Murphy is the founder and CEO of Rosecliff Ventures, a New York City-based...

Levine Leichtman Capital Partners has tapped its €463m Europe II fund again to back Prime Global Medical Communications.Prime Global, which was founded in...

The world’s biggest AI chip just doubled its specs—without adding an inch. The Cerebras Systems Wafer Scale Engine is about the size of a...

Michael B. Gray Contributor Michael B. Gray is partner and leader of the private equity, venture capital...

A company culture of growth Learn how your company's culture can either advance or totally sabotage...

News of NYMBUS’ $15 million fundraising this week – and the company’s recent appointment of three women to key leadership positions –...

When it comes to Alzheimer’s versus science, science is on the losing side. Alzheimer’s is cruel in the most insidious way. The disorder creeps...

The Neuralink ‘monkey test’ announced a few weeks ago by Elon Musk has come to a successful conclusion: the animal played Pong...

The pandemic has accelerated the digital shift in many industries and healthcare has been a primary beneficiary. While the rise in telehealth comes...

New funding: Outpace Bio raised a $30 million Series A investment round to design custom cell and gene-based therapies. The science: Founded in November,...

New funding: Eliem Therapeutics, a new Seattle biotech startup led by former Juno Therapeutics exec Bob Azelby, raised $80 million to develop clinically-validated...